MANEVSNIVF• 6 Months (Normalized)
MANE vs NIVF (Veradermics Incorporated vs NewGenIvf Group Limited)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MANE Performance $116.76
+101.17%
Veradermics Incorporated
Normalized Baseline0.00%
NIVF Performance $0.13
-99.35%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin MANE LEADS
+200.52 pts
MANE outperforming by 200.52 percentage points
MANENIVF
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MANE NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | MANE Price | MANE Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $116.76 | +101.17% | $0.13 | -99.35% | +200.52% |
| Oct 01, 2026 | $- | $0.10 | -99.49% | - | |
| Sep 30, 2026 | $- | $0.17 | -99.15% | - | |
| Sep 29, 2026 | $- | $0.07 | -99.63% | - | |
| Sep 28, 2026 | $- | $0.35 | -98.25% | - | |
| Sep 24, 2026 | $115.72 | +99.38% | $- | - | |
| Sep 23, 2026 | $115.78 | +99.48% | $0.59 | -97.01% | +196.49% |
| Sep 22, 2026 | $118.14 | +103.55% | $0.73 | -96.28% | +199.83% |
| Sep 21, 2026 | $112.80 | +94.35% | $0.72 | -96.35% | +190.70% |
| Sep 18, 2026 | $106.75 | +83.92% | $0.72 | -96.35% | +180.27% |
| Sep 17, 2026 | $108.68 | +87.25% | $0.72 | -96.37% | +183.62% |
| Sep 16, 2026 | $102.42 | +76.46% | $0.79 | -96.02% | +172.48% |
| Sep 15, 2026 | $103.89 | +79.00% | $0.84 | -95.74% | +174.74% |
| Sep 14, 2026 | $101.70 | +75.22% | $0.93 | -95.29% | +170.51% |
| Sep 11, 2026 | $98.97 | +70.52% | $1.06 | -94.62% | +165.14% |
Page 1 of 9